Yuki Gosei Kogyo Co., Ltd.

Everything filed on one company: the documents, the statements, the register, the board, the buyback and the property table — each figure as filed, with the report it came from.

Latest values as text and table

Yuki Gosei Kogyo Co., Ltd.

Yuki Gosei Kogyo Co., Ltd. (有機合成薬品工業株式会社, 4531), Pharmaceutical. 10 cross-shareholdings, a board of 6 and 10 largest shareholders, as filed on EDINET for the year to March 2026. EDINET filing S100YHPD, filed 2026-06-23. Source: company filings on EDINET (Financial Services Agency of Japan).

Financial summary

Five-year summary as filed, latest filing per fiscal year
Fiscal year endRevenue (¥bn)Profit (¥bn)Total assets (¥bn)EPS (¥)DPS (¥)Employees
2022-03-3112.40.221.211.374.00296
2023-03-3112.80.622.125.517.00295
2024-03-3112.90.824.435.578.00290
2025-03-3115.10.926.941.409.00296
2026-03-3115.40.325.714.5110.00296

Source: company filings on EDINET (Financial Services Agency of Japan). · JSON

Cross-shareholdings

Ten largest cross-shareholdings by book value, latest annual report
Company heldSharesBook value (¥bn)% of shares outstanding
ZERIA PHARMACEUTICAL CO., LTD.272,1000.60.6
SUMITOMO CORPORATION73,0000.40.0
ASKA Pharmaceutical Holdings Co., Ltd.150,0000.40.5
Mitsubishi UFJ Financial Group, Inc.105,9000.30.0
OSAKA SODA CO., LTD.119,5000.20.1
KUREHA CORPORATION46,5000.20.1
NIPRO CORPORATION100,0000.20.1
Mebuki Financial Group,Inc.104,9200.10.0
Tokyo Kiraboshi Financial Group, Inc.3,0190.00.0

% of shares outstanding: shares held ÷ (issuer's issued shares − treasury shares) × 100, both as filed, the denominator taken from the issuer's own annual securities report nearest the holding's fiscal year end

Source: company filings on EDINET (Financial Services Agency of Japan). · JSON · Markdown